Apobec3 Mouse shRNA Plasmid (Locus ID 80287)

SKU
TL505334
Apobec3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
  $1,013.00
2 Weeks*
Specifications
Specifications
Product Data
Locus ID 80287
Synonyms Apobec; Arp3; BC003314; Cem15; Rfv3
Vector pGFP-C-shLenti
E. coli Selection Chloramphenicol (34 ug/ml)
Mammalian Cell Selection Puromycin
Format Lentiviral plasmids
Components Apobec3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 80287). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq BC003314, NM_001160415, NM_001347041, NM_030255, NM_030255.1, NM_030255.2, NM_030255.3, NM_001160415.1, BC007182
UniProt ID Q99J72
Summary DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. Exhibits antiviral activity against HIV-1, simian immunodeficiency viruses (SIVs), mouse mammary tumor virus (MMTV) and friend murine leukemia virus (FrMLV) and may inhibit the mobility of LTR retrotransposons.UniProtKB/Swiss-Prot Function
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment
Evgin, Huff, Kottke et al
Cancer Immunol Res (2019) 7 (5), 828-840 DOI: 10.1158/2326-6066.CIR-18-0013
AI Summary: In this study, OriGene's APOBEC3B cDNA (RC202663) and APOBEC3B shRNA (TL313717) products were used to overexpress and knock down APOBEC3B in tumor cells, respectively, demonstrating that APOBEC3B modulates tumor cell escape from first-line therapies under suboptimal T-cell pressure.
FigureFigure
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products